Percutaneous tricuspid valve replacement: Orthotopic and heterotopic valves

Kimberly Calica Atianzar, Ming Zhang, Sameer Gafoor

Research output: Contribution to journalReview article

Abstract

The tricuspid valve has long been described as the “forgotten valve”, leaving tricuspid valve disease relatively neglected. However, the number of people in the United States affected by severe tricuspid regurgitation is growing. Isolated surgery for severe tricuspid regurgitation in the setting of right ventricular heart failure carries a high mortality risk, and therefore, attention to corrective therapies has increased. Because of the different etiologies for tricuspid regurgitation, multiple percutaneous transcatheter options for tricuspid valve repair for severe regurgitation are being studied and have been developed, including annuloplasty systems, leaflet and coaptation devices, vena caval (heterotopic) valve implantations, and tricuspid valve (orthotopic) replacement. In this paper, we review the heterotopic and orthotopic tricuspid valve transcatheter options for severe tricuspid regurgitation.

Original languageEnglish (US)
Pages (from-to)729-734
Number of pages6
JournalMinerva Cardioangiologica
Volume66
Issue number6
DOIs
StatePublished - Dec 1 2018

Fingerprint

Tricuspid Valve
Tricuspid Valve Insufficiency
Neglected Diseases
Venae Cavae
Heart Failure
Equipment and Supplies
Mortality

Keywords

  • Heterotopic
  • Surgery
  • Transplantation
  • Tricuspid valve insufficiency

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Percutaneous tricuspid valve replacement : Orthotopic and heterotopic valves. / Atianzar, Kimberly Calica; Zhang, Ming; Gafoor, Sameer.

In: Minerva Cardioangiologica, Vol. 66, No. 6, 01.12.2018, p. 729-734.

Research output: Contribution to journalReview article

@article{56bc3925753942c4ab7d7f5b0cee2ca9,
title = "Percutaneous tricuspid valve replacement: Orthotopic and heterotopic valves",
abstract = "The tricuspid valve has long been described as the “forgotten valve”, leaving tricuspid valve disease relatively neglected. However, the number of people in the United States affected by severe tricuspid regurgitation is growing. Isolated surgery for severe tricuspid regurgitation in the setting of right ventricular heart failure carries a high mortality risk, and therefore, attention to corrective therapies has increased. Because of the different etiologies for tricuspid regurgitation, multiple percutaneous transcatheter options for tricuspid valve repair for severe regurgitation are being studied and have been developed, including annuloplasty systems, leaflet and coaptation devices, vena caval (heterotopic) valve implantations, and tricuspid valve (orthotopic) replacement. In this paper, we review the heterotopic and orthotopic tricuspid valve transcatheter options for severe tricuspid regurgitation.",
keywords = "Heterotopic, Surgery, Transplantation, Tricuspid valve insufficiency",
author = "Atianzar, {Kimberly Calica} and Ming Zhang and Sameer Gafoor",
year = "2018",
month = "12",
day = "1",
doi = "10.23736/S0026-4725.18.04659-5",
language = "English (US)",
volume = "66",
pages = "729--734",
journal = "Minerva Cardioangiologica",
issn = "0026-4725",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "6",

}

TY - JOUR

T1 - Percutaneous tricuspid valve replacement

T2 - Orthotopic and heterotopic valves

AU - Atianzar, Kimberly Calica

AU - Zhang, Ming

AU - Gafoor, Sameer

PY - 2018/12/1

Y1 - 2018/12/1

N2 - The tricuspid valve has long been described as the “forgotten valve”, leaving tricuspid valve disease relatively neglected. However, the number of people in the United States affected by severe tricuspid regurgitation is growing. Isolated surgery for severe tricuspid regurgitation in the setting of right ventricular heart failure carries a high mortality risk, and therefore, attention to corrective therapies has increased. Because of the different etiologies for tricuspid regurgitation, multiple percutaneous transcatheter options for tricuspid valve repair for severe regurgitation are being studied and have been developed, including annuloplasty systems, leaflet and coaptation devices, vena caval (heterotopic) valve implantations, and tricuspid valve (orthotopic) replacement. In this paper, we review the heterotopic and orthotopic tricuspid valve transcatheter options for severe tricuspid regurgitation.

AB - The tricuspid valve has long been described as the “forgotten valve”, leaving tricuspid valve disease relatively neglected. However, the number of people in the United States affected by severe tricuspid regurgitation is growing. Isolated surgery for severe tricuspid regurgitation in the setting of right ventricular heart failure carries a high mortality risk, and therefore, attention to corrective therapies has increased. Because of the different etiologies for tricuspid regurgitation, multiple percutaneous transcatheter options for tricuspid valve repair for severe regurgitation are being studied and have been developed, including annuloplasty systems, leaflet and coaptation devices, vena caval (heterotopic) valve implantations, and tricuspid valve (orthotopic) replacement. In this paper, we review the heterotopic and orthotopic tricuspid valve transcatheter options for severe tricuspid regurgitation.

KW - Heterotopic

KW - Surgery

KW - Transplantation

KW - Tricuspid valve insufficiency

UR - http://www.scopus.com/inward/record.url?scp=85057105147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057105147&partnerID=8YFLogxK

U2 - 10.23736/S0026-4725.18.04659-5

DO - 10.23736/S0026-4725.18.04659-5

M3 - Review article

C2 - 29589668

AN - SCOPUS:85057105147

VL - 66

SP - 729

EP - 734

JO - Minerva Cardioangiologica

JF - Minerva Cardioangiologica

SN - 0026-4725

IS - 6

ER -